Accueil   Diary - News   All news CMI'nov is the winner of a SME Instrument Phase 1 project

CMI’nov is the winner of a SME Instrument Phase 1 project

 

The CMI'nov company, which specializes in the design and development of medical devices dedicated to minimally invasive cardiac surgery, is the winner of a SME Instrument Phase 1 project, co-funded by the European Commission, for 50,000 euros. The company answered brilliantly, ranking at the top of the list in France and Europe. The three requirements of the European Union are the Impact (Market - Intellectual Property), Excellence (innovative aspect of the project, risky and high potential) and Implementation (quality and efficiency of implementation). The project aims to analyze the feasibility of a product dedicated to the repair of the mitral valve and its replicability on the tricuspid valve. The ultimate ambition is to deploy a new gold standard in valvuloplasty worldwide.

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree